Tirzepatide Attenuates Cortical Inflammatory and Neuronal Alterations in Diabetic Rats: Associations with PI3K/AKT Phosphorylation and Conditioned Fear Responses

Background/Objectives: Tirzepatide lowers blood glucose, but its effects on diabetes-associated neurological dysfunction remain incompletely characterized. We examined conditioned fear responses and accompanying prefrontal cortical alterations in diabetic rats. Methods: Male Sprague Dawley rats with diabetes induced by a high-fat diet and streptozotocin received tirzepatide (1.35 mg/kg intraperitoneally, twice weekly) for 10 weeks. Metabolic and behavioral assessments included eight rats per group. Neuronal morphology, synapse-associated proteins, tau phosphorylation, inflammatory cytokines, PI3K/AKT phosphorylation, and autophagy-related proteins were examined in prefrontal cortical tissue. Results: Tirzepatide treatment was associated with improved glycemic control and oral glucose tolerance. The insulin-tolerance-test area under the curve did not differ significantly between treated and untreated diabetic rats (adjusted p = 0.0993). Treated diabetic rats showed higher freezing at 96 h (adjusted p = 0.0017), although the group-by-time interaction was not significant (p = 0.1308). Treatment was associated with fewer neurons showing degeneration-like morphology, higher PSD95 and SYT1 abundance, and lower tau phosphorylation at Thr205 and Ser404. Prefrontal cortical TNF-α, IL-6, and IL-1β expression decreased. Prefrontal cortical TNF-α and IL-1β mRNA levels and protein concentrations of TNF-α, IL-6, and IL-1β were lower following tirzepatide treatment, whereas the reduction in IL-6 mRNA was not statistically significant. PI3K/AKT phosphorylation and the abundance of autophagy-related proteins were also altered. Conclusions: The findings link tirzepatide treatment to metabolic, behavioral, inflammatory, and neuronal changes in diabetic rats. They do not establish PI3K/AKT causality, restored autophagic flux, or restored long-term memory. Direct central effects cannot be separated from the consequences of improved systemic metabolism. Initial conditioning differences and the absence of independent locomotor and shock-sensitivity assessments limit the behavioral interpretation. Nissl morphology and synaptic protein abundance do not independently establish neuronal viability or improved synaptic function.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-19
DOI
https://doi.org/10.3390/ph19111841
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tirzepatide Attenuates Cortical Inflammatory and Neuronal Alterations in Diabetic Rats: Associations with PI3K/AKT Phosphorylation and Conditioned Fear Responses

Xiaosong Yang, Min Lei, Xiying Guo, Xiufen Liu et al.
Pharmaceuticals
Neuroscience and Neuropharmacology Research
article

Tirzepatide Attenuates Cortical Inflammatory and Neuronal Alterations in Diabetic Rats: Associations with PI3K/AKT Phosphorylation and Conditioned Fear Responses

Xiaosong Yang, Min Lei, Xiying Guo, Xiufen Liu, Qingjie Chen, Changhan Ouyang, Yuqing Zhang, Mingjing Chen
article en

Abstract

Background/Objectives: Tirzepatide lowers blood glucose, but its effects on diabetes-associated neurological dysfunction remain incompletely characterized. We examined conditioned fear responses and accompanying prefrontal cortical alterations in diabetic rats. Methods: Male Sprague Dawley rats with diabetes induced by a high-fat diet and streptozotocin received tirzepatide (1.35 mg/kg intraperitoneally, twice weekly) for 10 weeks. Metabolic and behavioral assessments included eight rats per group. Neuronal morphology, synapse-associated proteins, tau phosphorylation, inflammatory cytokines, PI3K/AKT phosphorylation, and autophagy-related proteins were examined in prefrontal cortical tissue. Results: Tirzepatide treatment was associated with improved glycemic control and oral glucose tolerance. The insulin-tolerance-test area under the curve did not differ significantly between treated and untreated diabetic rats (adjusted p = 0.0993). Treated diabetic rats showed higher freezing at 96 h (adjusted p = 0.0017), although the group-by-time interaction was not significant (p = 0.1308). Treatment was associated with fewer neurons showing degeneration-like morphology, higher PSD95 and SYT1 abundance, and lower tau phosphorylation at Thr205 and Ser404. Prefrontal cortical TNF-α, IL-6, and IL-1β expression decreased. Prefrontal cortical TNF-α and IL-1β mRNA levels and protein concentrations of TNF-α, IL-6, and IL-1β were lower following tirzepatide treatment, whereas the reduction in IL-6 mRNA was not statistically significant. PI3K/AKT phosphorylation and the abundance of autophagy-related proteins were also altered. Conclusions: The findings link tirzepatide treatment to metabolic, behavioral, inflammatory, and neuronal changes in diabetic rats. They do not establish PI3K/AKT causality, restored autophagic flux, or restored long-term memory. Direct central effects cannot be separated from the consequences of improved systemic metabolism. Initial conditioning differences and the absence of independent locomotor and shock-sensitivity assessments limit the behavioral interpretation. Nissl morphology and synaptic protein abundance do not independently establish neuronal viability or improved synaptic function.

PharmaceuticalsVol. 19(11)
Hubei University of Science and Technology (CN)
Neuroscience and Neuropharmacology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon